These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34413964)

  • 1. Discovery of VU6028418: A Highly Selective and Orally Bioavailable M
    Spock M; Carter TR; Bollinger KA; Han C; Baker LA; Rodriguez AL; Peng L; Dickerson JW; Qi A; Rook JM; O'Neill JC; Watson KJ; Chang S; Bridges TM; Engers JL; Engers DW; Niswender CM; Conn PJ; Lindsley CW; Bender AM
    ACS Med Chem Lett; 2021 Aug; 12(8):1342-1349. PubMed ID: 34413964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of VU0467485/AZ13713945: An M
    Wood MR; Noetzel MJ; Melancon BJ; Poslusney MS; Nance KD; Hurtado MA; Luscombe VB; Weiner RL; Rodriguez AL; Lamsal A; Chang S; Bubser M; Blobaum AL; Engers DW; Niswender CM; Jones CK; Brandon NJ; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    ACS Med Chem Lett; 2017 Feb; 8(2):233-238. PubMed ID: 28197318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
    Suwa A; Konishi Y; Uruno Y; Takai K; Nakako T; Sakai M; Enomoto T; Ochi Y; Matsuda H; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2909-12. PubMed ID: 24852118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of the First Selective M
    Moehle MS; Bender AM; Dickerson JW; Foster DJ; Qi A; Cho HP; Donsante Y; Peng W; Bryant Z; Stillwell KJ; Bridges TM; Chang S; Watson KJ; O'Neill JC; Engers JL; Peng L; Rodriguez AL; Niswender CM; Lindsley CW; Hess EJ; Conn PJ; Rook JM
    ACS Pharmacol Transl Sci; 2021 Aug; 4(4):1306-1321. PubMed ID: 34423268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M
    Bender AM; Carter TR; Spock M; Rodriguez AL; Dickerson JW; Rook JM; Chang S; Qi A; Presley CC; Engers DW; Harp JM; Bridges TM; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2022 Jan; 56():128479. PubMed ID: 34838649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Selective and High Affinity Radioligand, [
    Qi A; Kling HE; Billard N; Rodriguez AL; Peng L; Dickerson JW; Engers JL; Bender AM; Moehle MS; Lindsley CW; Rook JM; Niswender CM
    Mol Pharmacol; 2023 Nov; 104(5):195-202. PubMed ID: 37595966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
    Bubser M; Bridges TM; Dencker D; Gould RW; Grannan M; Noetzel MJ; Lamsal A; Niswender CM; Daniels JS; Poslusney MS; Melancon BJ; Tarr JC; Byers FW; Wess J; Duggan ME; Dunlop J; Wood MW; Brandon NJ; Wood MR; Lindsley CW; Conn PJ; Jones CK
    ACS Chem Neurosci; 2014 Oct; 5(10):920-42. PubMed ID: 25137629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia.
    Downs AM; Donsante Y; Jinnah HA; Hess EJ
    Neurobiol Dis; 2022 Jun; 168():105699. PubMed ID: 35314320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic chick heart expresses multiple muscarinic acetylcholine receptor subtypes. Isolation and characterization of a gene encoding a novel m2 muscarinic acetylcholine receptor with high affinity for pirenzepine.
    Tietje KM; Nathanson NM
    J Biol Chem; 1991 Sep; 266(26):17382-7. PubMed ID: 1840593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of PCS1055, a novel muscarinic M4 receptor antagonist.
    Croy CH; Chan WY; Castetter AM; Watt ML; Quets AT; Felder CC
    Eur J Pharmacol; 2016 Jul; 782():70-6. PubMed ID: 27085897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro.
    Carr BJ; Mihara K; Ramachandran R; Saifeddine M; Nathanson NM; Stell WK; Hollenberg MD
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2778-2791. PubMed ID: 29860464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres.
    Yang Q; Lachapelle EA; Kablaoui NM; Webb D; Popiolek M; Grimwood S; Kozak R; O'Connor RE; Lazzaro JT; Butler CR; Zhang L
    ACS Med Chem Lett; 2019 Jun; 10(6):941-948. PubMed ID: 31223452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the M
    Moehle MS; Conn PJ
    Mov Disord; 2019 Aug; 34(8):1089-1099. PubMed ID: 31211471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M
    Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK
    Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
    Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
    ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
    Watt ML; Rorick-Kehn L; Shaw DB; Knitowski KM; Quets AT; Chesterfield AK; McKinzie DL; Felder CC
    Neuropsychopharmacology; 2013 Dec; 38(13):2717-26. PubMed ID: 23907402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype-selective contribution of muscarinic acetylcholine receptors for filial imprinting in newly-hatched domestic chicks.
    Aoki N; Mori C; Fujita T; Serizawa S; Yamaguchi S; Matsushima T; Homma KJ
    Behav Brain Res; 2022 Apr; 424():113789. PubMed ID: 35151794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists.
    Bender AM; Weiner RL; Luscombe VB; Ajmera S; Cho HP; Chang S; Zhan X; Rodriguez AL; Niswender CM; Engers DW; Bridges TM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3576-3581. PubMed ID: 28633897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
    Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.